Clinical pathways may require a deeper consideration of the patient experience in order to achieve the goals of the Triple Aim, according to Winston Wong, PharmD.
CAR T-cell therapy may compliment HSCT for improving survival in ALL without increasing the risk of severe graft-versus-host disease, according to research presented at the 2018 BMT Tandem Meetings.
A recent study compared the effects of a collaborative care intervention vs usual care on health status of patients with chronic heart failure.
The NCCN has selected Envision's medical affairs platform to help manage proposals and investigator-initiated clinical trials in an effort to improve patient quality of life and reduce cancer-related deaths.
The National Comprehensive Cancer Network has released the first-ever clinical practice guidelines addressing patients living with HIV who are diagnosed with cancer to help them receive safe and necessary treatment.
The US Food and Drug Administration has granted approval to a therapy in combination with an aromatase inhibitor for the treatment of a specific type of advanced breast cancer.
Women with breast cancer are often afraid of getting radiation, but a new study of women who’ve had this treatment suggests their experiences with it were much better than they expected.
The National Comprehensive Cancer Network issued updated guidelines for prostate cancer, including new information about the role of family history, specific mutations, and microsatellite instability testing.
Commercial payers are spending almost twice as much on chemotherapy administered in hospital outpatient departments compared with therapy administered in physician offices.
A study to be presented at the BMT Tandem Meetings found no difference in OS for patients aged 55-64 years compared with those aged 65 years and older with non-Hodgkin lymphoma who underwent alloHCT.